Use of thiadiazolo4,3-apyridine derivatives

Abstract From the Canadian patent

Use of compounds of the formula (I), in which X and X identically or , differently, are hydrogen a C - to C -alkyl radical or a halogen atom or if , they are in adjacent positions, form a fused phenyl ring together with the carbon atoms carrying them, and R is an optionally substituted carbocyclic or heterocyclic saturated or unsaturated radical and their physiologically , tolerable salts for the production of medicaments for diseases which are modulated via inhibition of phosphodiesterase(s) by cyclic nucleotides in , particular cyclic adenosine monophosphate. The diseases are more particularly proliferative disorders, including tumors lymphomas, leukaemias, atherosclerosis and …